Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) (349026)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    Cause areas available with a free TheShareWay account.

    This grant supports exploratory research into the biology of high confidence risk factors associated with complex brain disorders, focusing on the cellular and molecular substrates of neural function. It encourages studies that may be either hypothesis-generating or hypothesis-testing, utilizing various experimental paradigms, including in vivo, in situ, or in vitro approaches. Proposals should aim to elucidate the neurobiological impact of risk factors, without the requirement to model the disorders themselves. Research that enriches data resources for broader scientific utility, particularly in understanding disease risk, biological mechanisms, and therapeutic target identification, is sought. This announcement specifically seeks R21 applications for high-risk or early-stage research.

    Eligibility

    Organization's Location
    Eligible organization locations available with a free TheShareWay account.
    Program Location
    Program locations available with a free TheShareWay account.
    Organization Type
    Eligible organization types available with a free TheShareWay account.

    Submission

    Visit Apply for more information.

    Similar grants